Cargando…
Efficacy of an unmodified bivalent mRNA vaccine against SARS-CoV-2 variants in female small animal models
Combining optimized spike (S) protein-encoding mRNA vaccines to target multiple SARS-CoV-2 variants could improve control of the COVID-19 pandemic. We compare monovalent and bivalent mRNA vaccines encoding B.1.351 (Beta) and/or B.1.617.2 (Delta) SARS-CoV-2 S-protein in a transgenic mouse and a Wista...
Autores principales: | Corleis, Björn, Hoffmann, Donata, Rauch, Susanne, Fricke, Charlie, Roth, Nicole, Gergen, Janina, Kovacikova, Kristina, Schlottau, Kore, Halwe, Nico Joel, Ulrich, Lorenz, Schön, Jacob, Wernike, Kerstin, Widera, Marek, Ciesek, Sandra, Mueller, Stefan O., Mettenleiter, Thomas C., Maione, Domenico, Petsch, Benjamin, Beer, Martin, Dorhoi, Anca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9924835/ https://www.ncbi.nlm.nih.gov/pubmed/36781853 http://dx.doi.org/10.1038/s41467-023-36110-1 |
Ejemplares similares
-
Assessment of Immunogenicity and Efficacy of CV0501 mRNA-Based Omicron COVID-19 Vaccination in Small Animal Models
por: Roth, Nicole, et al.
Publicado: (2023) -
CVnCoV and CV2CoV protect human ACE2 transgenic mice from ancestral B BavPat1 and emerging B.1.351 SARS-CoV-2
por: Hoffmann, Donata, et al.
Publicado: (2021) -
Animal models for COVID-19 and tuberculosis
por: Corleis, Björn, et al.
Publicado: (2023) -
Experimental SARS-CoV-2 Infection of Bank Voles
por: Ulrich, Lorenz, et al.
Publicado: (2021) -
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus
por: Wolff, Janika, et al.
Publicado: (2020)